IBDEI0VB ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15483,1,3,0)
 ;;=3^276.0
 ;;^UTILITY(U,$J,358.3,15483,1,4,0)
 ;;=4^HYPERNATREMIA
 ;;^UTILITY(U,$J,358.3,15483,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,15484,0)
 ;;=276.7^^95^943^9
 ;;^UTILITY(U,$J,358.3,15484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15484,1,3,0)
 ;;=3^276.7
 ;;^UTILITY(U,$J,358.3,15484,1,4,0)
 ;;=4^HYPERPOTASSEMIA
 ;;^UTILITY(U,$J,358.3,15484,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,15485,0)
 ;;=275.41^^95^943^10
 ;;^UTILITY(U,$J,358.3,15485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15485,1,3,0)
 ;;=3^275.41
 ;;^UTILITY(U,$J,358.3,15485,1,4,0)
 ;;=4^HYPOCALCEMIA
 ;;^UTILITY(U,$J,358.3,15485,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,15486,0)
 ;;=588.89^^95^943^11
 ;;^UTILITY(U,$J,358.3,15486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15486,1,3,0)
 ;;=3^588.89
 ;;^UTILITY(U,$J,358.3,15486,1,4,0)
 ;;=4^HYPOKALEMIC NEPHROPATHY
 ;;^UTILITY(U,$J,358.3,15486,2)
 ;;=^88036
 ;;^UTILITY(U,$J,358.3,15487,0)
 ;;=276.1^^95^943^12
 ;;^UTILITY(U,$J,358.3,15487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15487,1,3,0)
 ;;=3^276.1
 ;;^UTILITY(U,$J,358.3,15487,1,4,0)
 ;;=4^HYPONATREMIA
 ;;^UTILITY(U,$J,358.3,15487,2)
 ;;=^60722
 ;;^UTILITY(U,$J,358.3,15488,0)
 ;;=275.3^^95^943^13
 ;;^UTILITY(U,$J,358.3,15488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15488,1,3,0)
 ;;=3^275.3
 ;;^UTILITY(U,$J,358.3,15488,1,4,0)
 ;;=4^HYPOPHOSPHATEMIA
 ;;^UTILITY(U,$J,358.3,15488,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,15489,0)
 ;;=276.8^^95^943^14
 ;;^UTILITY(U,$J,358.3,15489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15489,1,3,0)
 ;;=3^276.8
 ;;^UTILITY(U,$J,358.3,15489,1,4,0)
 ;;=4^HYPOPOTASSEMIA
 ;;^UTILITY(U,$J,358.3,15489,2)
 ;;=^60611
 ;;^UTILITY(U,$J,358.3,15490,0)
 ;;=276.52^^95^943^15
 ;;^UTILITY(U,$J,358.3,15490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15490,1,3,0)
 ;;=3^276.52
 ;;^UTILITY(U,$J,358.3,15490,1,4,0)
 ;;=4^HYPOVOLEMIA
 ;;^UTILITY(U,$J,358.3,15490,2)
 ;;=^332744
 ;;^UTILITY(U,$J,358.3,15491,0)
 ;;=276.4^^95^943^16
 ;;^UTILITY(U,$J,358.3,15491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15491,1,3,0)
 ;;=3^276.4
 ;;^UTILITY(U,$J,358.3,15491,1,4,0)
 ;;=4^MIXED ACID-BASE DISORDER
 ;;^UTILITY(U,$J,358.3,15491,2)
 ;;=^267945
 ;;^UTILITY(U,$J,358.3,15492,0)
 ;;=588.1^^95^943^17
 ;;^UTILITY(U,$J,358.3,15492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15492,1,3,0)
 ;;=3^588.1
 ;;^UTILITY(U,$J,358.3,15492,1,4,0)
 ;;=4^NEPHROGEN DIABETES INSIP
 ;;^UTILITY(U,$J,358.3,15492,2)
 ;;=^276848
 ;;^UTILITY(U,$J,358.3,15493,0)
 ;;=276.50^^95^943^18
 ;;^UTILITY(U,$J,358.3,15493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15493,1,3,0)
 ;;=3^276.50
 ;;^UTILITY(U,$J,358.3,15493,1,4,0)
 ;;=4^VOLUME DEPLETION NOS
 ;;^UTILITY(U,$J,358.3,15493,2)
 ;;=^332840
 ;;^UTILITY(U,$J,358.3,15494,0)
 ;;=584.9^^95^944^1
 ;;^UTILITY(U,$J,358.3,15494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15494,1,3,0)
 ;;=3^584.9
 ;;^UTILITY(U,$J,358.3,15494,1,4,0)
 ;;=4^ACUTE RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,15494,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,15495,0)
 ;;=285.21^^95^944^2
 ;;^UTILITY(U,$J,358.3,15495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15495,1,3,0)
 ;;=3^285.21
 ;;^UTILITY(U,$J,358.3,15495,1,4,0)
 ;;=4^ANEMIA SECONDARY/ESRD
 ;;^UTILITY(U,$J,358.3,15495,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,15496,0)
 ;;=285.29^^95^944^3
 ;;^UTILITY(U,$J,358.3,15496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15496,1,3,0)
 ;;=3^285.29
 ;;^UTILITY(U,$J,358.3,15496,1,4,0)
 ;;=4^ANEMIA SECONDARY/OTH CHR ILLNESS
 ;;^UTILITY(U,$J,358.3,15496,2)
 ;;=^334228
 ;;^UTILITY(U,$J,358.3,15497,0)
 ;;=585.9^^95^944^10
 ;;^UTILITY(U,$J,358.3,15497,1,0)
 ;;=^358.31IA^4^2
